Therapeutic Asset Ratings
748 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Personalized Neoantigen Tumor Vaccine
B-Cell Non-Hodgkin Lymphoma
Ruijin Hospital
P1
CC
(43)
Polyphenol Whole Tumor Cell Vaccine
Cancer
Xingchen Peng
P1
CC
(43)
Polyphenol Whole Tumor Cell Vaccine
Polyphenols
Xingchen Peng
P1
CC
(43)
Ppsv23
Bladder Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Quadrivalent Inactivated Influenza Vaccine
Cutaneous Melanoma
Carlo Contreras
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Histiocytic and Dendritic Cell Neoplasm
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Recurrent Adult Acute Myeloid Leukemia
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Recurrent Angioimmunoblastic T-Cell Lymphoma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Recurrent Plasma Cell Myeloma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Recurrent T-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
Rocakinogene Sifuplasmid
Hepatitis
National Cancer Institute (NCI)
P1
CC
(43)
Rocakinogene Sifuplasmid
Hepatitis C Virus Infection
National Cancer Institute (NCI)
P1
CC
(43)
Survaxm
Anaplastic Ependymoma
Children's Oncology Group
P1
CC
(43)
Survaxm
Anaplastic Oligodendroglioma
Children's Oncology Group
P1
CC
(43)
Survaxm
Ependymoma
Children's Oncology Group
P1
CC
(43)
Survaxm
High Grade Astrocytic Tumor
Children's Oncology Group
P1
CC
(43)
Survaxm
Medulloblastoma
Children's Oncology Group
P1
CC
(43)
Survaxm
Plasma Cell Myeloma
Roswell Park Cancer Institute
P1
CC
(43)
Tetanus Toxoid
Bladder Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
tp53-epha-2-car-dc
EphA2 Overexpression
Chinese PLA General Hospital
P1
CC
(43)
tp53-epha-2-car-dc
TP53 R175H
Chinese PLA General Hospital
P1
CC
(43)
tp53-epha-2-car-dc
TP53 R248Q
Chinese PLA General Hospital
P1
CC
(43)
tp53-epha-2-car-dc
Li-Fraumeni Syndrome
Chinese PLA General Hospital
P1
CC
(43)
Vsv-Gp128
Colon Adenocarcinoma
Amal Therapeutics
P1
CC
(43)
Showing 501 to 525 of 748 assets
Previous
Page 21 of 30
Next
